Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B

Overview of attention for article published in Molecular Autism, August 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Stem Cell Secretions as a Potential Therapeutic Agent for Autism Spectrum Disorder: A Narrative Review

Article in Stem Cell Reviews and Reports (April 2024)

The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases

Article in Nano Today (April 2024)

Exosome lncRNA IFNG-AS1 derived from mesenchymal stem cells of human adipose ameliorates neurogenesis and ASD-like behavior in BTBR mice

Article in Journal of Nanobiotechnology (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.